Taysha Gene Therapies Shares Resume Trade
Portfolio Pulse from Benzinga Newsdesk
Shares of Taysha Gene Therapies have resumed trading.
August 14, 2023 | 1:53 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Taysha Gene Therapies' shares have resumed trading, which could lead to increased market activity around the stock.
The resumption of trading for a company's shares typically leads to increased market activity as investors react to the news. However, it's uncertain whether this will lead to a rise or fall in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100